Puma Biotechnology reported $114.28M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amgen AMGN:US $ 19322M 802M
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Clovis Oncology CLVS:US $ 142.28M 43.25M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
Exelixis EXEL:US $ 1851.64M 8.9M
Gilead Sciences GILD:US $ 13705M 1076M
Glaxosmithkline GSK:US $ 54188M 25200M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Macrogenics MGNX:US $ 167.63M 50.57M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Moderna Inc MRNA:US 13.56B 2.79B
Novartis NOVN:VX 38.14B 906M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
Spectrum Pharmaceuticals SPPI:US $ 93.18M 10.77M
Takeda 4502:JP Y 2549515M 44127M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vanda Pharmaceuticals VNDA:US $ 496.9M 4.63M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
YTE INCY:US $ 3625.84M 337.75M